TRexBio Closes $84M Series B to Advance Immune-Based Therapeutics
Key Highlights TRexBio raises $84M in Series B led by Delos Capital with new investors Avego BioScience and Agent…
Browsing Tag
Johnson & Johnson Innovation – JJDC
3 posts
SpectraWAVE Secures $50M in Series B to Advance HyperVue™ Imaging System for Coronary Artery Disease Treatment
Key Highlights SpectraWAVE raises $50M in Series B led by Johnson & Johnson Innovation – JJDC, Inc. HyperVue™ Imaging…
Capstan Therapeutics Secures $175M in Series B
Key Highlights $175M Series B financing led by RA Capital Management with broad investor participation. Funds to advance CPTX2309, Capstan’s…